The prestigious 2025 China Hainan-Southeast Asia & South Asia Digestive Endoscopy International Forum and Medical-Engineering Transformation Innovation Summit concluded successfully from November 21st to 23rd at the Haikou Renaissance Hotel. This gathering served as a pivotal platform for leading experts and clinicians to explore the future of digestive endoscopy. As an innovator in endoscopic hemostasis, the Xunning® team made a significant impact at the event, presenting its core products—the Absorbable Complex Polysaccharide Hemostatic Powder and the second-generation Endoscopic Hemostasis Device—sparking keen interest and discussion among attendees.
A Forum for Innovation and Exchange
The international forum brought together top-tier endoscopists and physicians from China, Southeast Asia, and South Asia. Discussions centered on the latest technological advancements, complex case studies, and the critical path of medical-engineering transformation—turning innovative ideas into practical clinical tools. This focus on translational medicine aligns perfectly with Xunning®’s core mission of developing solutions that directly address unmet clinical needs.
Xunning® Takes the Stage: Showcasing a Benchmark in Hemostasis
At the forum, the Xunning® team highlighted its comprehensive hemostasis solution:
- Flagship Product: Absorbable Composite Polysaccharide Hemostatic Powder
- Rapid Hemostasis: Acts quickly on the wound site, forming a physical barrier and promoting coagulation. It is particularly effective for diffuse oozing bleeding and hard-to-suture areas.
- Fully Absorbable: After fulfilling its hemostatic purpose, the powder is naturally absorbed by the body, eliminating the need for a second removal procedure and enhancing patient comfort.
- Ease of Use: Designed for delivery through the endoscopic channel via a specialized device, it simplifies the surgical procedure and saves valuable time.
- Enhanced Technology: Second-Generation Endoscopic Hemostasis Device
- This upgraded device offers significant improvements in precision, maneuverability, and stability. It ensures even and accurate powder dispersion over the bleeding site, providing physicians with a more reliable tool for managing complex hemostatic scenarios.
Earning Recognition: Xunning®’s “Three Key Advantages”
During academic sessions and product demonstrations, Xunning® garnered high praise from global experts for its distinct “Three Key Advantages”:
- Advantage 1: Proven Clinical Efficacy – Demonstrated rapid and reliable hemostasis in simulations and clinical feedback, effectively reducing the risk of re-bleeding.
- Advantage 2: Superior Safety Profile – As a bio-absorbable material, it boasts excellent tissue compatibility with minimal side effects.
- Advantage 3: Unmatched Operational Convenience – The integrated system design streamlines the process from preparation to application, shortening procedure time and boosting overall efficiency.
Rooted in Progress, Focused on the Future
The conclusion of this forum marks not an end, but the beginning of a renewed journey. The invaluable feedback and exchanges with international experts have further solidified Xunning®’s commitment to innovation-driven development.
Moving forward, Xunning® will continue to deepen its roots in the field of endoscopic hemostasis, dedicating resources to R&D, refining product details, and advancing technological capabilities.
Xunning®’s mission remains steadfast: to provide safer, faster, and more precise hemostatic solutions, empowering clinicians to confidently tackle complex challenges and ultimately improve patient outcomes worldwide.